MBX Biosciences (MBX) Interest & Investment Income (2023 - 2026)

MBX Biosciences has reported Interest & Investment Income for 4 years, with the latest figure at $3.7 million in Q1 2026.

• Quarterly Interest & Investment Income rose 41.49% year-over-year to $3.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $14.8 million (up 65.12% YoY) and the FY2025 annual result came in at $11.1 million, up 76.72% from the prior year.
• Interest & Investment Income retreated to $3.7 million in Q1 2026 per MBX's latest filing, from $11.0 million in the prior quarter.
• Over five years, Interest & Investment Income peaked at $11.0 million in Q4 2025 and troughed at -$63000.0 in Q1 2024.
• A 4-year average of $2.2 million and a median of $121000.0 in 2024 frame the typical range for Interest & Investment Income.
• The sharpest annual moves came in 2024 and 2025: Interest & Investment Income surged 11429.63% in 2024, then sank 250.0% in 2025.
• Over 4 years, Interest & Investment Income stood at $54000.0 in 2023, then jumped by 11429.63% to $6.2 million in 2024, then soared by 76.44% to $11.0 million in 2025, then sank by 65.88% to $3.7 million in 2026.
• According to Business Quant data, Interest & Investment Income over the past three periods registered $3.7 million, $11.0 million, and $143000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.